icon
View Focus Area

Lung Cancer Biomarker Testing ECHO Year 3

December 2023

-

May 2024

Introduction to ECHO and Biomarker Testing Guidelines Overview

This session provided an overview of the ECHO model, along with providing a data level-set of the current burden of lung cancer in each state, and provide a brief introduction to lung cancer biomarker testing, including the current guidelines and approved FDA biomarker-driven treatments.

Didactic Presenter

DuyKhanh Pham “Mimi” Ceppa, MD, FACS

Aakash Desai, MBBS, MPH

Understanding the Barriers and Pathways to Lung Cancer Biomarker Testing

This session will provide an overview of the biomarker continuum through the lens of the critical medical stakeholders, showcasing the coordinated sequence of events that is required and the common gaps at every stage of the multidisciplinary care continuum.

Didactic Presenter

Millie Das, MD

Adequate Tissue for Sampling

This session will define the overall role of the multidisciplinary care team, including the coordination by pathologists and medical oncologists to ensure adequate lung cancer tissue is collected for testing. Additionally, it will provide guidance on how to procure adequate tissue samples that allow for accurate characterization of histology, biomarker testing, and the tissue and discuss the approaches of the different proceduralists.

Didactic Presenter

Nichole T. Tanner, MD, MSCR

Choice of Panel, Interpretation of Results, and Next Steps

This session will provide guidance and recommendations regarding the appropriate biomarker testing modalities (next-generation sequencing (NGS), Fluorescence in situ hybridization (FISH), and blood. Additionally, it will discuss how to interpret the current NGS reports and the appropriate next steps, e.g. recommendations for FDA approved treatments or cancer clinical trials (if no FDA approved treatment exists, etc.).

Didactic Presenter

Ignacio Wistuba, MD

Improving Turnaround Time

This session will offer strategies to reduce turnaround time and present approaches to help ameliorate the patient’s wait time for the results.

Didactic Presenter

Jason Merker, MD, PhD

Navigating Insurance Challenges

This session will explore the current coverage policies and reimbursement for single gene tests, as compared to multi-gene panel tests by private and public payers in each state and provide solutions to overcome reimbursement barriers.

Didactic Presenters

Hilary Goeckner, MSW

Cori Chandler, MPA

Our Experts

expert-head-shot

Bruce Johnson, MD, FASCO

Professor of Medicine, Harvard Medical School

Senior Advisor to the President,

 

expert-head-shot

Timothy Mullett, MD, MBA, FACS

Medical Director, Markey Cancer Center Network Development

expert-head-shot

Millie Das, MD

Chief, Oncology

VA Palo Alto Health Care System

Clinical Associate Professor

expert-head-shot

Aakash Desai, MBBS, MPH

Assistant Professor Of Medicine

O’Neal Cancer Center

 

expert-head-shot

Grace Dy, MD

Professor of Oncology

 

expert-head-shot

DuyKhanh Pham “Mimi” Ceppa, MD, FACS

Associate Professor of Thoracic Surgery

 

expert-head-shot

Matthew Facktor, MD

System Chief, Thoracic Surgery

 

expert-head-shot

Adam Fox, MD

Assistant Professor

 

expert-head-shot

Jason Merker, MD, PhD

Associate Professor, Department of Pathology and Laboratory Medicine & Genetics

University of North Carolina

 

expert-head-shot

Koosha Paydary, MD, MPH, MSc

Assistant Professor, Department of Internal Medicine

 

expert-head-shot

Catherine R. Sears, MD

Associate Professor of Medicine, Division of Pulmonary, Critical Care, Sleep and Occupational Medicine

Indiana University School of Medicine

 

expert-head-shot

Michal Senitko, MD

Assistant Professor

 

expert-head-shot

Gerard Silvestri, MD, MS

Hillenbrand Professor of Thoracic Oncology

 

expert-head-shot

Heather Wakelee, MD

Professor of Medicine and Chief of the Division of Oncology, Stanford University School of Medicine

Deputy Director,

expert-head-shot

Ignacio Wistuba, MD

Professor and Chair, Department of Translational Pathology

 

expert-head-shot

Nichole T. Tanner, MD, MSCR

Professor of Medicine

 

expert-head-shot

Cori Chandler, MPA

Sr. State & Local Campaigns Manager

expert-head-shot

Hilary Goeckner, MSW

Director, State & Local Campaigns

Collected Program Resources

Financial Support Provided By

  • Sponsor Logo

Need Assistance

Complete the fields below to learn more about how the American Cancer Society uses the ECHO Model to fight cancer on all fronts, inquire about an upcoming ECHO, or to learn how you can join us in our mission to save lives, celebrate lives, and lead the fight for a world without cancer.

Contact Us

Involved-2

Support the American Cancer Society ECHO program with a contribution.

This Website is administered by the American Cancer Society, Inc. on behalf of the Office of Cancer Research & Implementation. Copyright © 2024 American Cancer Society ECHO American Cancer Society, Inc.

Privacy Policy